文献速递乳腺病理细胞病理与分子病理

乳腺肿瘤二代测序遗传图谱:少见类型与基因型-表型关联

Genetic landscapes of breast tumors by next-generation sequencing with focus on less common types and genotype-phenotype correlations.
PubMed 文献 · Hum Pathol · 2025-06-04

本文综述二代测序(NGS)在乳腺肿瘤中的应用,重点描述少见或罕见组织学类型及其他乳腺肿瘤的遗传图谱。许多病变具有高度特异的突变或重排/基因融合,部分可用免疫组化或RNA原位杂交替代标志物评估,有助于准确诊断并可能提示治疗靶点。

要点

  • 少见乳腺肿瘤常携带特异性突变或基因融合,可辅助病理诊断。
  • 部分遗传改变有免疫组化或RNA原位杂交替代标志物可在光镜下评估。
  • 血管肉瘤等部分亚型无特异性遗传基础,但富集特定遗传特征和致癌通路。

核心结论

  • 少见乳腺肿瘤的遗传图谱已逐步阐明,特征性遗传改变或其分子替代物有助于准确诊断并可能提示治疗靶点。

主要发现

  • 浸润性小叶癌、伴反向极性的高细胞癌、多数涎腺样肿瘤、纤维上皮性肿瘤及纤维瘤病、结节性筋膜炎和隆突性皮肤纤维肉瘤等间叶肿瘤具有高度特异的突变或重排/基因融合。
  • 血管肉瘤、三阴性大汗腺癌、化生性癌及部分ER阳性癌(黏液癌、微乳头状癌、神经内分泌肿瘤)无特异性遗传基础,但富集某些遗传特征和致癌通路。
  • 部分病例的替代免疫组化或RNA原位杂交标志物与 underlying 遗传改变相关,可在光镜下评估。

临床怎么用

  • 识别特征性遗传改变或其分子替代物可用于建立准确诊断。
  • 部分遗传改变可能指向可操作的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Next-generation sequencing (NGS) has transformed our understanding of oncogenic pathways and mutational processes underlying many breast tumors. Although large-scale NGS studies included mostly common invasive breast carcinomas, the genetic landscapes of several less common or rare special histologic types and other breast tumors have now also been elucidated. Many of these lesions harbor highly specific types of mutations or rearrangements/gene fusions, including invasive lobular carcinoma, tall cell carcinoma with reversed polarity, most salivary gland-like neoplasms, fibroepithelial neoplasms, and mesenchymal tumors such as fibromatosis, nodular fasciitis, and dermatofibrosarcoma protuberans. In some cases, surrogate immunohistochemical or RNA in situ hybridization markers evaluable by light microscopy have been shown to correlate with the underlying genetic alterations. Angiosarcomas and other special breast cancer subtypes, such as triple negative apocrine carcinomas, metaplastic carcinomas, and a subset of ER-positive carcinomas (mucinous and micropapillary carcinomas, neuroendocrine neoplasms) have not been associated with specific genetic underpinnings but are enriched for certain genetic features and oncogenic pathways. The identification of characteristic genetic alterations or their molecular surrogates can be useful to establish an accurate diagnosis, and in some cases, may point to potentially actionable therapeutic targets. This review aims to summarize the genetic landscapes of less common benign and malignant breast tumors, with special attention to genotype-phenotype correlations and to the diagnostic utility of genetics and surrogate markers when applicable. BRCA1/2-associated breast carcinomas will also be discussed due to the association of so-called BRCAness with basal-like histology.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Hoda RS, Krings G. Genetic landscapes of breast tumors by next-generation sequencing with focus on less common types and genotype-phenotype correlations. Hum Pathol. 2025. PMID: 40480318. doi:10.1016/j.humpath.2025.105826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。